Literature DB >> 22036173

[Imported malaria in adults. Clinical, epidemiological and analytical features].

G Ramírez-Olivencia1, M D Herrero, M Subirats, J R de Juanes, J M Peña, S Puente.   

Abstract

INTRODUCTION: Up to now, the epidemiological and clinical features of imported malaria in Spain have been described in small series from general hospitals. Almost all diagnosis had been made based on symptomatic patients. The aim of this study has been to determine the epidemiological, clinical and laboratorial characteristics of imported malaria in a Reference Unit for Tropical Diseases. PATIENTS AND METHODS: We performed a cross-sectional, observational and retrospective study. The series consisted of patients diagnosed of malaria who had been attended at the Hospital Carlos III from January 1, 2002 to December 31, 2007.
RESULTS: We identified 484 episodes of malaria, of which 398 cases were included in the analysis. Almost 50% of the patients were natives of endemic areas, while the rest were native-travelers or travelers. Most cases (88-98% according to the group) had not taken malaria chemoprophylaxis correctly when indicated. At the time of diagnosis, 30.4% of patients were asymptomatic and 28.1% of asymptomatic patients had anemia, 19.8% thrombocytopenia, 14% leukopenia, 5% hypocholesterolemia, 5% renal failure and 4.1% hypoglycemia. Low parasitemia was present in 97.5% of asymptomatic individuals compared to 80.5% of the symptomatic patients (P<0.001). DISCUSSION: Absence of chemoprophylaxis (or poor compliance) is the main reason for malaria in individuals traveling to endemic areas. Malaria must be ruled out in individuals coming from tropical countries with compatible symptoms, and it also should be suspected in certain groups of asymptomatic individuals with abnormal laboratorial parameters.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036173     DOI: 10.1016/j.rce.2011.07.017

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  6 in total

1.  Imported submicroscopic malaria in Madrid.

Authors:  Germán Ramírez-Olivencia; José Miguel Rubio; Pablo Rivas; Mercedes Subirats; María Dolores Herrero; Mar Lago; Sabino Puente
Journal:  Malar J       Date:  2012-09-12       Impact factor: 2.979

Review 2.  Serum lipids and lipoproteins in malaria--a systematic review and meta-analysis.

Authors:  Benjamin J Visser; Rosanne W Wieten; Ingeborg M Nagel; Martin P Grobusch
Journal:  Malar J       Date:  2013-12-07       Impact factor: 2.979

3.  Imported malaria cases: the connection with the European ex-colonies.

Authors:  Marta Domínguez García; Cristina Feja Solana; Alberto Vergara Ugarriza; Cruz Bartolomé Moreno; Elena Melús Palazón; Rosa Magallón Botaya
Journal:  Malar J       Date:  2019-12-04       Impact factor: 2.979

4.  [Prevention and diagnosis of imported malaria in primary care: Asturias 2002-2012].

Authors:  Ana Gancedo-García; Lucía Terán-Álvarez; Carmen Toyos-Munárriz; Michal Chudácik; Patricio Suárez-Gil
Journal:  Aten Primaria       Date:  2014-05-03       Impact factor: 1.137

5.  Impact of using artemisinin-based combination therapy (ACT) in the treatment of uncomplicated malaria from Plasmodium falciparum in a non-endemic zone.

Authors:  Joaquín Pousibet-Puerto; Joaquín Salas-Coronas; Alicia Sánchez-Crespo; M Angustias Molina-Arrebola; Manuel J Soriano-Pérez; M José Giménez-López; José Vázquez-Villegas; M Teresa Cabezas-Fernández
Journal:  Malar J       Date:  2016-07-02       Impact factor: 2.979

6.  Prospective comparative multi-centre study on imported Plasmodium ovale wallikeri and Plasmodium ovale curtisi infections.

Authors:  Gerardo Rojo-Marcos; José Miguel Rubio-Muñoz; Andrea Angheben; Stephane Jaureguiberry; Silvia García-Bujalance; Lina Rachele Tomasoni; Natalia Rodríguez-Valero; José Manuel Ruiz-Giardín; Joaquín Salas-Coronas; Juan Cuadros-González; Magdalena García-Rodríguez; Israel Molina-Romero; Rogelio López-Vélez; Federico Gobbi; María Calderón-Moreno; Esteban Martin-Echevarría; Matilde Elía-López; José Llovo-Taboada
Journal:  Malar J       Date:  2018-10-30       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.